Rote William E.
Travere Therapeutics, Inc. · Chief Research Officer
Rote William E. is listed in filings as Chief Research Officer at Travere Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 6, 2026, including sale activity. Recent filings connect the profile to Travere Therapeutics, Inc. (TVTX). The current snapshot covers public activity from Jan 23, 2025 to May 6, 2026. Reported amounts are shown as $121.4K to $409.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $356k9.1k shares | SellApr 22, 2026 | $39.09 | $55.74 | |
| $409k12.4k shares | SellFeb 3, 2026 | $32.87 | $55.74 | |
| $2M60k shares | SellDec 24, 2025 | $40.10 | $55.74 | |
| $67k3.2k shares | SellMay 5, 2025 | $21.05 | $55.74 | |
| $122k5.2k shares | SellFeb 12, 2025 | $23.53 | $55.74 | |
| $177k9k shares | SellFeb 3, 2025 | $19.78 | $55.74 | |
| $47k2.4k shares | SellJan 22, 2025 | $19.46 | $55.74 |